Suraksha Diagnostic Ltd. (IN:SURAKSHA)
:SURAKSHA
Want to see IN:SURAKSHA full AI Analyst Report?
SURAKSHA Stock Chart & Stats
₹300.85
-₹13.40(-3.48%)
At close: 4:00 PM EST
₹300.85
-₹13.40(-3.48%)
Day’s Range― - ―
52-Week Range₹224.10 - ₹353.65
Previous CloseN/A
Volume140.52K
Average Volume (3M)1.23K
Market Cap
₹14.02B
Enterprise Value₹15.92B
Total Cash (Recent Filing)₹435.94M
Total Debt (Recent Filing)₹1.18B
Price to Earnings (P/E)43.3
Beta1.13
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.13
Shares Outstanding52,080,757
10 Day Avg. Volume1,073
30 Day Avg. Volume1,225
Financial Highlights & Ratios
PEG Ratio32.20
Price to Book (P/B)4.85
Price to Sales (P/S)3.82
P/FCF Ratio70.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.7
Revenue Forecast (FY)₹3.35B
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue GrowthConsistent multi-year top-line expansion demonstrates sustained end-market demand and effective commercial execution. Such revenue momentum allows the company to scale fixed costs, support reinvestment in network and services, and underpins medium-term cash generation and strategic options.
Operating Cash GenerationOperating cash flow materially exceeding accounting profit signals high earnings quality and strong cash-producing operations. This provides durable internal funding for working capital and investments, reduces reliance on external financing, and supports balance-sheet resilience over the coming quarters.
Healthy Operating ProfitabilitySustained mid-to-high operating and EBITDA margins indicate structural efficiency and pricing or mix advantages versus peers. Durable profitability cushions the business against cyclical headwinds, supports reinvestment and margin recovery efforts, and sustains cash flow generation over time.
Bears Say
Margin CompressionSharp FY26 margin declines suggest persistent pricing pressure, cost inflation, or adverse mix, which can erode durable profitability. If structural, compressed gross and net margins reduce free cash available for debt paydown or investment and heighten sensitivity to volume swings across the medium term.
Rising LeverageIncreasing debt levels raise financial risk and interest burden, limiting flexibility for capex or strategic M&A. With returns softening (ROE down vs prior year), higher leverage makes the company more vulnerable to margin or cash-flow shocks and constrains long-term capital allocation choices.
Weak Free-Cash-Flow ConversionLow FCF conversion means reported earnings translate poorly into distributable cash, likely due to capex or working-capital demands. Persistently weak conversion can force external funding for growth, slow deleveraging, and limit shareholder returns, undermining financial durability over months.
Suraksha Diagnostic Ltd. News
SURAKSHA FAQ
What was Suraksha Diagnostic Ltd.’s price range in the past 12 months?
Suraksha Diagnostic Ltd. lowest stock price was ₹224.10 and its highest was ₹353.65 in the past 12 months.
What is Suraksha Diagnostic Ltd.’s market cap?
Suraksha Diagnostic Ltd.’s market cap is ₹14.02B.
When is Suraksha Diagnostic Ltd.’s upcoming earnings report date?
Suraksha Diagnostic Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 51 days.
How were Suraksha Diagnostic Ltd.’s earnings last quarter?
Suraksha Diagnostic Ltd. released its earnings results on May 21, 2026. The company reported ₹1.21 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.21.
Is Suraksha Diagnostic Ltd. overvalued?
According to Wall Street analysts Suraksha Diagnostic Ltd.’s price is currently Overvalued.
Does Suraksha Diagnostic Ltd. pay dividends?
Suraksha Diagnostic Ltd. does not currently pay dividends.
What is Suraksha Diagnostic Ltd.’s EPS estimate?
Suraksha Diagnostic Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Suraksha Diagnostic Ltd. have?
Suraksha Diagnostic Ltd. has 52,080,757 shares outstanding.
What happened to Suraksha Diagnostic Ltd.’s price movement after its last earnings report?
Suraksha Diagnostic Ltd. reported an EPS of ₹1.21 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.73%.
Which hedge fund is a major shareholder of Suraksha Diagnostic Ltd.?
Currently, no hedge funds are holding shares in IN:SURAKSHA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Suraksha Diagnostic Ltd.
Founded in Kolkata in 1992 as Suraksha Diagnostics & Eye Centre (P) Ltd., the company revolutionized diagnostic services in the city by being among the first to offer a full spectrum of pathology and radiology services under one roof. This integrated approach, coupled with an unwavering commitment to precision and patient care, led to consistent growth and widespread recognition. Within just three years, they expanded their footprint by opening a second center in Siliguri, North Bengal. This Siliguri facility continues to be the largest diagnostic center in the region, serving patients not only from North Bengal but also from neighboring states and countries. Since then, Suraksha Diagnostic Limited has continued its steady expansion, establishing a presence across Bengal, Bihar, and the Delhi National Capital Region.
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Thyrocare Technologies Ltd
―
Vimta Labs Limited
―